Over 90% of diabetic patients are diagnosed as having type 2 diabetes mellitus (T2DM), which is typically characterized by obesity, reduced insulin sensitivity, increased insulin secretion, and chronic inflammation in tissues (Lee and Olefsky 2021; Zheng et al. 2018). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.